ANUH PHARMA
Back to Income Statement
|
ANUH PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹772 Cr | ₹662 Cr | ₹647 Cr | ₹527 Cr | ₹487 Cr |
What is the latest Revenue of ANUH PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹772 Cr |
| Mar2025 | ₹662 Cr |
| Mar2024 | ₹647 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹487 Cr |
How is Revenue of ANUH PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹772 Cr | 16.65 | |
| Mar2025 | ₹662 Cr | 2.24 | |
| Mar2024 | ₹647 Cr | 22.66 | |
| Mar2023 | ₹527 Cr | 8.39 | |
| Mar2022 | ₹487 Cr | - | |
Compare Revenue of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹793.2 Cr | -0.9% | -12.9% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -0.9% |
-12.9% |
-3.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses